Evidence map›Paper›PMID 36034459›Full record

ArticleFrontiers in endocrinology2022

OPN inhibits autophagy through CD44, integrin and the MAPK pathway in osteoarthritic chondrocytes.

Rui-Jun Bai, Di Liu, Yu-Sheng Li, Jian Tian, Deng-Jie Yu, Heng-Zhen Li, Fang-Jie Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rui-Jun BaiDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
Di LiuDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
Yu-Sheng LiDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
Jian TianDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
Deng-Jie YuDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
Heng-Zhen LiDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
Fang-Jie ZhangNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To investigate whether osteopontin (OPN) affects autophagy in human osteoarthritic chondrocytes and determine the roles of CD44, αvβ3 integrin and the Mitogen-activated protein kinase (MAPK) pathway in this progress. Methods: First, we compared the autophagy levels in the human osteoarthritis (OA) and normal cartilage, then, we cultured human OA chondrocytes Results: The LC3 protein was greatly decreased in OA cartilage compared to normal cartilage, and OPN suppressed the autophagy activity in chondrocytes Conclusion: OPN inhibited chondrocyte autophagy through CD44 and αvβ3 integrin receptors and

Indexed as

ChondrocytesOsteoarthritisAutophagyBeclin-1HumansHyaluronan ReceptorsIntegrinsMitogen-Activated Protein KinasesOsteopontinBeclin-1CD44 protein, humanHyaluronan ReceptorsIntegrinsMitogen-Activated Protein KinasesOsteopontinautophagyCD44chondrocyteintegrinosteoarthritisosteopontin

Identifiers

PMID36034459
PMCPMC9411521
OpenAlexW4291162277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.